Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Adma Biologics (ADMA) Tax Provisions: 2011-2024

Historic Tax Provisions for Adma Biologics (ADMA) over the last 3 years, with Dec 2024 value amounting to -$72.0 million.

  • Adma Biologics' Tax Provisions rose 1219.88% to $11.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$53.7 million, marking a year-over-year decrease of 1265.17%. This contributed to the annual value of -$72.0 million for FY2024, which is N/A change from last year.
  • As of FY2024, Adma Biologics' Tax Provisions stood at -$72.0 million, which was down 11,551.11% from -$617,615 recorded in FY2012.
  • In the past 5 years, Adma Biologics' Tax Provisions ranged from a high of -$72.0 million in FY2024 and a low of -$72.0 million during FY2024.
  • In the last 1 years, Adma Biologics' Tax Provisions had a median value of -$72.0 million in 2024 and averaged -$72.0 million.